Clinical Rheumatology · Nov 18, 2026
Clinical and demographic characteristics of patients with fragility fractures: a 3-year experience of a Fracture Liaison Service
By Bayır YB, Seyhun CM, Yılmaz ZA et al.
Objective The aim of this study was to evaluate the clinical characteristics of individuals with fragility fractures assessed in our outpatient clinic, which serves as a Fracture Liaison Service (FLS) center, and to identify risk factors associated with subsequent fractures. Methods Patients with fragility fractures who presented at the Physical Medicine and Rehabilitation Outpatient Clinic, which served as an FLS between October 2022 and May 2025, were reviewed retrospectively. Results A total of 1006 patients were included; new fragility fractures were detected in 29 (2.9%) during the follow-up. There was no significant difference in the incidence of new fractures between patients with and without regular follow-ups in the FLS (p = 0.373). Medication adherence was significantly higher in patients who were followed up regularly (p < 0.001). Multivariate analysis suggested associations of age and a history of fracture under treatment with subsequent new fracture occurrence (OR, 1.040, p = 0.039; OR, 15.848, p < 0.001, respectively). Only a history of osteoporosis treatment was identified as an independent risk factor for complete medication adherence (OR = 1.820, p = 0.004). The time since presentation (p < 0.001, OR = 1.534), the presence of a forearm fracture (p = 0.001, OR = 1.792), and medication adherence (p < 0.001, OR = 4.762) were found to be independent risk factors affecting the follow-up status. Conclusion In patients with fragility fractures, timely initiation of appropriate pharmacological treatment, lifestyle modifications, and regular monitoring may contribute to improved secondary fracture prevention strategies. Although no significant difference in new fracture incidence was observed between patients with and without regular FLS follow-up, regular monitoring was associated with higher medication adherence. Therefore, structured FLS follow-up may support treatment adherence and continuity of post-fracture care, although its effect on subsequent fracture incidence could not be demonstrated in this study. Key Points • This three-year FLS experience provides real-world data on the clinical characteristics, treatment adherence, and subsequent fracture risk in patients with fragility fractures. • Regular FLS follow-up was associated with significantly higher medication adherence, although subsequent fracture incidence did not differ significantly according to follow-up status. • Older age and fracture occurrence during ongoing osteoporosis treatment were independently associated with subsequent fragility fractures. • Previous osteoporosis treatment was independently associated with medication adherence, while longer time since initial presentation, forearm fracture, and medication adherence were independently associated with regular follow-up.
doi.org/10.1007/s10067-026-08532-xPubMed 43045939Populations